CHART Trademark

Trademark Overview

On Wednesday, June 21, 2017, a trademark application was filed for CHART with the United States Patent and Trademark Office. The USPTO has given the CHART trademark a serial number of 87499653. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, February 1, 2021. This trademark is owned by Amicus Therapeutics, Inc.. The CHART trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of diseases, namely, lysosomal storage disorders and diseases of neurodegeneration
chart

General Information

Serial Number87499653
Word MarkCHART
Filing DateWednesday, June 21, 2017
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, February 1, 2021
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, October 31, 2017

Trademark Statements

Goods and ServicesPharmaceutical preparations for the treatment of diseases, namely, lysosomal storage disorders and diseases of neurodegeneration

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, June 28, 2017
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameAmicus Therapeutics, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressPhiladelphia, PA 19104
Party NameAmicus Therapeutics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressCranbury, NJ 08512

Trademark Events

Event DateEvent Description
Monday, February 1, 2021ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, February 1, 2021ABANDONMENT - NO USE STATEMENT FILED
Thursday, January 28, 2021APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Thursday, January 28, 2021TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, January 28, 2021TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, July 21, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, July 20, 2020EXTENSION 5 GRANTED
Friday, June 26, 2020EXTENSION 5 FILED
Friday, July 17, 2020CASE ASSIGNED TO INTENT TO USE PARALEGAL
Friday, June 26, 2020TEAS EXTENSION RECEIVED
Thursday, December 26, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, December 24, 2019EXTENSION 4 GRANTED
Tuesday, December 24, 2019EXTENSION 4 FILED
Tuesday, December 24, 2019TEAS EXTENSION RECEIVED
Thursday, June 27, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, June 25, 2019EXTENSION 3 GRANTED
Tuesday, June 25, 2019EXTENSION 3 FILED
Tuesday, June 25, 2019TEAS EXTENSION RECEIVED
Friday, December 7, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, December 5, 2018EXTENSION 2 GRANTED
Wednesday, December 5, 2018EXTENSION 2 FILED
Wednesday, December 5, 2018TEAS EXTENSION RECEIVED
Tuesday, April 24, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, April 20, 2018EXTENSION 1 GRANTED
Friday, April 20, 2018EXTENSION 1 FILED
Friday, April 20, 2018TEAS EXTENSION RECEIVED
Tuesday, December 26, 2017NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, October 31, 2017OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, October 31, 2017PUBLISHED FOR OPPOSITION
Wednesday, October 11, 2017NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Saturday, September 23, 2017APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, September 19, 2017ASSIGNED TO EXAMINER
Wednesday, June 28, 2017NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Saturday, June 24, 2017NEW APPLICATION ENTERED IN TRAM

Related Keywords

chart diseases storage disorders neurodegeneration lysosomal namely preparations treatment pharmaceutical